Adenovir Pharma AB

Quick facts

Phase 2 pipeline

• APD-209 Eye drops · Ophthalmology
  APD-209 Eye drops are designed to reduce inflammation in the eye by inhibiting the action of a specific enzyme.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Adenovir Pharma AB portfolio CI brief
• Adenovir Pharma AB pipeline updates RSS